Expertise in
4
conditions

Dr. Roshanak Monzavi

Pediatric Endocrinology
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 

Expertise in
4
conditions
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Roshanak Monzavi is a Pediatric Endocrinologist in Los Angeles, California. Dr. Monzavi is highly rated in 4 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Familial Short Stature (FSS), and Idiopathic Short Stature (ISS).

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Licenses
Pediatric Endocrinology in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 5 Less Insurance Carriers -

Locations

Children's Hospital Los Angeles
4650 W Sunset Blvd, Los Angeles, CA 90027
Call: 323-361-4606

Additional Areas of Focus

Dr. Monzavi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Biological
Study Drugs: Afrezza, Rapid-acting Insulin Analog, Basal Insulin
Study Phase: Phase 3
An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years
An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Drug
Study Drug: Glucagon
Study Phase: Phase 1
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
Enrollment Status: Completed
Publish Date: May 08, 2017
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 5 Less Clinical Trials

16 Total Publications

INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
Journal: Diabetes care
Published: August 13, 2025
View All 16 Publications
Similar Doctors
Expertise in
20
conditions
Dr. Mitchell Geffner
Pediatric Endocrinology
Expertise in
20
conditions
Dr. Mitchell Geffner
Pediatric Endocrinology

Children's Hospital Los Angeles

4650 W Sunset Blvd, 
Los Angeles, CA 
 (0.1 miles away)
323-361-4606
Languages Spoken:
English
See accepted insurances

Mitchell Geffner is a Pediatric Endocrinologist in Los Angeles, California. Dr. Geffner is highly rated in 20 conditions, according to our data. His top areas of expertise are Congenital Adrenal Hyperplasia (CAH), Intersex, Ovarian Overproduction of Androgens, Short Stature (Growth Disorders), and Hormone Replacement Therapy (HRT).

Expertise in
3
conditions
Dr. Francine Kaufman
Pediatric Endocrinology
Expertise in
3
conditions
Dr. Francine Kaufman
Pediatric Endocrinology

Office

4650 W Sunset Blvd # 61, 
Los Angeles, CA 
 (0.1 miles away)
323-361-4606
Languages Spoken:
English
See accepted insurances

Francine Kaufman is a Pediatric Endocrinologist in Los Angeles, California. Dr. Kaufman is highly rated in 3 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Expertise in
10
conditions
Dr. Lynda E. Polgreen
Pediatric Endocrinology
Expertise in
10
conditions
Dr. Lynda E. Polgreen
Pediatric Endocrinology
1201 W La Veta Ave, 
Orange, CA 
 (32.7 miles away)
714-509-8634
Languages Spoken:
English
See accepted insurances

Lynda Polgreen is a Pediatric Endocrinologist in Orange, California. Dr. Polgreen is highly rated in 10 conditions, according to our data. Her top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Osteotomy.

VIEW MORE Pediatric Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Monzavi's expertise for a condition
ConditionClose
      • Advanced
      • Familial Short Stature (FSS)
        Dr. Monzavi is
        Advanced
        . Learn about Familial Short Stature (FSS).
        See more Familial Short Stature (FSS) experts
      • Idiopathic Short Stature (ISS)
        Dr. Monzavi is
        Advanced
        . Learn about Idiopathic Short Stature (ISS).
        See more Idiopathic Short Stature (ISS) experts
      • Short Stature (Growth Disorders)
        Dr. Monzavi is
        Advanced
        . Learn about Short Stature (Growth Disorders).
        See more Short Stature (Growth Disorders) experts
      • Type 1 Diabetes (T1D)
        Dr. Monzavi is
        Advanced
        . Learn about Type 1 Diabetes (T1D).
        See more Type 1 Diabetes (T1D) experts
      • Experienced
      • Adrenal Insufficiency Pediatric
        Dr. Monzavi is
        Experienced
        . Learn about Adrenal Insufficiency Pediatric.
        See more Adrenal Insufficiency Pediatric experts
      • Cardiofaciocutaneous Syndrome
        Dr. Monzavi is
        Experienced
        . Learn about Cardiofaciocutaneous Syndrome.
        See more Cardiofaciocutaneous Syndrome experts
      • Cardiomyopathic Lentiginosis
        Dr. Monzavi is
        Experienced
        . Learn about Cardiomyopathic Lentiginosis.
        See more Cardiomyopathic Lentiginosis experts
      • Congenital Adrenal Hyperplasia (CAH)
        Dr. Monzavi is
        Experienced
        . Learn about Congenital Adrenal Hyperplasia (CAH).
        See more Congenital Adrenal Hyperplasia (CAH) experts
      • Congenital Hypothyroidism
        Dr. Monzavi is
        Experienced
        . Learn about Congenital Hypothyroidism.
        See more Congenital Hypothyroidism experts
      • Diabetic Ketoacidosis
        Dr. Monzavi is
        Experienced
        . Learn about Diabetic Ketoacidosis.
        See more Diabetic Ketoacidosis experts
      View All 23 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      1. Homepage
      2. Pediatric Endocrinologists Los Angeles, CA
      3. Dr. Roshanak Monzavi
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.